Predominant expression of B7-H1 and its immunoregulatory roles in oral squamous cell carcinoma

Oral Oncology

Volumn 42, Issue 3, 2006, Pages 268-274

  Tsushima, Fumihiko ^a,b   Tanaka, Kae ^a   Otsuki, Noriko ^a   Youngnak, Pornpan ^a,c   Iwai, Hideyuki ^a   Omura, Ken ^a   Azuma, Miyuki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

B7 family molecules; B7 H1; Immunoregulation; Oral cancer

Indexed keywords

ALLOANTIGEN; B7 ANTIGEN; B7 DC ANTIGEN; B7 H1 ANTIGEN; B7H ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CELL SURFACE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; INOCULATION; MOUSE; MOUTH CARCINOMA; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; UPREGULATION;

ANIMALS; ANTIGENS, CD80; ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; FEMALE; FLOW CYTOMETRY; HUMANS; INTERFERON TYPE II; MICE; MICE, INBRED C3H; MOUTH NEOPLASMS;

EID: 32644484710     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2005.07.013     Document Type: Article

References (27)

1. R.J. Greenwald, G.J. Freeman, and A.H. Sharpe The B7 family revisited Annu Rev Immunol 23 2004 515 548
2. A. Aicher, M. Hayden-Ledbetter, and W.A. Brady Characterization of human inducible costimulator ligand expression and function J Immunol 164 2000 4689 4696
3. H. Dong, G. Zhu, K. Tamada, and L. Chen B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion Nat Med 5 1999 1365 1369
4. S.Y. Tseng, M. Otsuji, and K. Gorski B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells J Exp Med 193 2001 839 846
5. T. Yamazaki, H. Akiba, and H. Iwai Expression of PD-1 ligands by murine T cells and antigen-presenting cells J Immunol 169 2002 5538 5545
6. N. Koga, J. Suzuki, and H. Kosuge Blockade of the interaction between PD-1 and PD-L1 accelerates graft arterial disease in cardiac allografts Arterioscler Thromb Vase Biol 24 2004 2057 2062
7. A. Nakazawa, I. Dotan, and J. Brimnes The expression and function of costimulatory molecules B7H and B7-H1 on colonic epithelial cells Gastroenterology 126 2004 1347 1357
8. M. Tsuda, K. Matsumoto, and H. Inoue Expression of B7-H1 and B7-DC on the airway epithelium is enhanced by double-stranded RNA Biochem Biophys Res Commun 330 2005 263 270
9. + T cells Proc Natl Acad Sci USA 99 2002 6198 6203
10. Y. Latchman, C.R. Wood, and T. Chernova PD-L2 is a second ligand for PD-1 and inhibits T cell activation Nat Immunol 2 2001 261 268
11. H. Dong, S.E. Strome, and D.R. Salomao Tumor-associated B7-Hl promotes T-cell apoptosis: a potential mechanism of immune evasion Nat Med 8 2002 793 800
12. T.J. Curiel, S. Wei, and H. Dong Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity Nat Med 9 2003 562 567
13. S. Wintterle, B. Schreiner, and M. Mitsdoerffer Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis Cancer Res 63 2003 7462 7467
14. S.E. Strome, H. Dong, and H. Tamura B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma Cancer Res 63 2003 6501 6505
15. Y. Iwai, M. Ishida, Y. Tanaka, T. Okazaki, T. Honjo, and N. Minato Involvement of PD-Ll on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade Proc Natl Acad Sci USA 99 2002 12293 12297
16. K. Matsumoto, T. Nakamura, and R.H. Kramer Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (pl25FAK) and promotes migration and invasion by oral squamous cell carcinoma cells J Biol Chem 269 1994 31807 31813
17. S. Mogi, J. Sakurai, and T. Kohsaka Tumour rejection by gene transfer of 4-1BB ligand into a CD80(+) murine squamous cell carcinoma and the requirements of co-stimulatory molecules on tumour and host cells Immunology 101 2000 541 547
18. P. Youngnak, Y. Kozono, and H. Kozono Differential binding properties of B7-H1 and B7-DC to programmed death-1 Biochem Biophys Res Commun 307 2003 672 677
19. M. Azuma, D. Ito, and H. Yagita B70 antigen is a second ligand for CTLA-4 and CD28 Nature 366 1993 76 79
20. M. Azuma, M. Cayabyab, D. Buck, J.H. Phillips, and L.L. Lanier CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes J Exp Med 175 1992 353 360
21. F. Tsushima, H. Iwai, and N. Otsuki Preferential contribution of B7-H1 to programmed death-1-mediated regulation of hapten-specific allergic inflammatory responses Eur J Immunol 33 2003 2773 2782
22. H. Iwai, Y. Kozono, and S. Hirose Amelioration of collagen-induced arthritis by blockade of inducible costimulator-B7 homologous protein costimulation J Immunol 169 2002 4332 4339
23. H. Nishimura, Y. Agata, and A. Kawasaki Developmentally regulated expression of the PD-1 protein on the surface of double-negative (CD4-CD8-) thymocytes Int Immunol 8 1996 773 780
24. S. Nuriya, H. Yagita, K. Okumura, and M. Azuma The differential role of CD86 and CD80 co-stimulatory molecules in the induction and the effector phases of contact hypersensitivity Int Immunol 8 1996 917 926
25. J. Konishi, K. Yamazaki, M. Azuma, I. Kinoshita, H. Dosaka-Akita, and M. Nishimura B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression Clin Cancer Res 10 2004 5094 5100
26. Y. Ohigashi, M. Sho, and Y. Yamada Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer Clin Cancer Res 11 2005 2947 2953
27. Y. Iwai, S. Terawaki, and T. Honjo PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells Int Immunol 17 2005 133 144